Real World Experience of Contemporary Pulmonary Embolism Treatment (USCDT versus MT): Insights From Big Data Analytics (REAL-PE)

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; Medtronic; Amgen; Penumbra
• Grant Support/Research Contract - Abbott; Biotronik